Clinical Trials Logo

Baroreflex clinical trials

View clinical trials related to Baroreflex.

Filter by:
  • None
  • Page 1

NCT ID: NCT02339506 Active, not recruiting - Clinical trials for Stress, Physiological

Stress and the Nervous System

Start date: April 2015
Phase: N/A
Study type: Interventional

Models of stress such as hypoglycemia have identified that stress results the next day in decreased baroreflex sensitivity. This project will test the hypothesis that these delayed changes in autonomic nervous system function are secondary to a rise in ACTH. The investigators will infuse cosyntropin versus placebo in a double-blind, crossover study in healthy adults and measure the delayed effects on the autonomic system as measured by cardiovagal baroreflex sensitivity.

NCT ID: NCT02210923 Recruiting - Clinical trials for Hypertension Resistant To Conventional Therapy

Effect Baroreflex Activation Therapy on the Carotid Body

Start date: October 2013
Phase: N/A
Study type: Observational

Carotid baroreflex activation therapy (BAT) by the Rheos® system produces a sustained fall in blood pressure in patients with resistant hypertension. Since the activation electrodes are implanted at the level of the carotid sinus, it is conceivable that the nearby located carotid body chemoreceptors are stimulated as well. Physiological stimulation of carotid chemoreceptors not only raises respiration, but it also increases sympathetic activity which may in part counteract the effects of BAT. The aim of the present study is to investigate whether there is evidence for concomitant carotid chemoreflex activation during BAT. We hypothesized that there is no clinically relevant co-activation of the carotid body chemoreceptors during BAT in patients with resistant hypertension.